University of Helsinki

08/13/2025 | Press release | Distributed by Public on 08/13/2025 04:26

Multidrug-resistant bacteria spread from war-zone hospitals to other countries

Multidrug-resistant bacteria spread from war-zone hospitals to other countries

Multidrug-resistant bacteria spread in war-zone hospitals and reach other countries too, carried particularly by patients with war injuries. This presents healthcare challenges but poses no risk outside hospital settings.

After Russia's full-scale invasion, thousands of patients have been transferred from Ukraine to other European countries. A study by the University of Helsinki and HUS Helsinki University Hospital showed that 8% of Ukrainian refugees had been hospitalised due to war injuries. Almost 80% of them carried multidrug resistant (MDR) bacteria.

Highest risk among patients hospitalised with war injuries


The study found that non-hospitalised refugees carried no more multidrug-resistant bacteria than previously shown for Finns who had travelled in Asia, Africa or South America.

"Concerns about the risk of antimicrobial resistance relate specifically to patients who have been hospitalised in conflict-affected areas. Patients with war injuries were found to carry highly resistant bacteria, which often caused serious infections," says Professor Anu Kantele of the University of Helsinki, who led the study.

Multidrug-resistant bacteria spread across borders


Healthcare systems in war zones are particularly vulnerable to the spread of multidrug-resistant bacteria.

"Hospitals in such areas are overburdened, and effective infection prevention is impossible. These conditions facilitate the spread of difficult-to-treat bacteria," notes Kantele.

Ukrainian refugees who had not been hospitalised abroad before arriving in Finland were clearly less likely to carry multidrug-resistant bacteria. They were found to carry mainly ESBL-producing E. coli bacteria and, in individual patients, MRSA bacteria.

"Ordinary citizens need not worry. The problem relates specifically to hospital settings," emphasises Doctoral Researcher Tuomas Aro, who is specialising in infectious diseases.

The Finnish healthcare system is prepared to tackle the challenge. At Finnish hospitals, patients previously hospitalised abroad are placed in single rooms, with contact isolation measures in place and bacterial samples taken.

"It's important to understand that the prevalence of antimicrobial resistance is no more common among ordinary refugees than among Finns after a trip to Asia, for instance," says Kantele.

The study was conducted as part of the Finnish Multidisciplinary Centre of Excellence in Antimicrobial Resistance Research (FIMAR), funded by the Research Council of Finland.

Further information:

Professor Anu KanteleUniversity of Helsinki and HUS Helsinki University [email protected]+358503097640Tuomas Aro, MDUniversity of Helsinki and HUS Helsinki University [email protected]+358505452343

13.8.2025

University of Helsinki

News

  • Public health

Share this page

Newsletter

University of Helsinki published this content on August 13, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on August 13, 2025 at 10:26 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]